Enovis Executive and Leadership Team

Ben Berry, the Chief Financial Officer at Enovis, directs all global fiscal operations and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures alignment between budgetary resources and the development of clinically differentiated medical technologies. This leadership role involves managing investor relations, optimizing cost structures, and supporting the long-term growth objectives of the company. By maintaining rigorous financial controls, Ben Berry directly impacts the ability of the firm to invest in research and development for patient-focused solutions. Furthermore, the Chief Financial Officer collaborates with the executive team to evaluate potential acquisitions and market expansions that strengthen the global footprint of the business. Through disciplined fiscal management, Berry secures the necessary capital to sustain the mission of restoring patient motion and improving healthcare outcomes across diverse international markets.

Judith MacGowan, the Regional Chief Financial Officer (APAC) at Enovis, manages all fiscal planning and reporting activities across the Asia-Pacific region. Overseeing regional financial performance, the Regional Chief Financial Officer (APAC) ensures that local operations adhere to corporate standards while adapting to the unique regulatory and market demands of the territory. This leadership role involves driving profitability through efficient resource allocation and supporting the expansion of medical technology distribution networks. By analyzing regional economic trends, Judith MacGowan provides critical insights that inform the broader strategic direction of the company. Furthermore, the Regional Chief Financial Officer (APAC) coordinates with local leadership to optimize supply chain costs and enhance the delivery of patient-centered solutions. Through meticulous oversight of regional assets, MacGowan strengthens the competitive position of the organization within the rapidly evolving healthcare landscape of the Asia-Pacific market.

Louie Vogt, the Group President, Reconstructive at Enovis, leads the development and commercialization of advanced orthopedic solutions designed to restore patient motion. Overseeing the reconstructive product portfolio, the Group President, Reconstructive ensures that clinical innovations meet the evolving needs of surgeons and healthcare providers. This leadership role involves driving market penetration through the introduction of personalized medical technologies and integrated care systems. By fostering partnerships with leading medical experts, Louie Vogt directly impacts the efficacy and adoption of reconstructive surgical tools. Furthermore, the Group President, Reconstructive coordinates with research and development teams to accelerate the pipeline of clinically differentiated products. Through the strategic management of the reconstructive business unit, Vogt supports the overarching mission of the company to improve patient lives by providing effective, high-performance solutions that address complex orthopedic challenges on a global scale.

Gary Justak, the Global President and General Manager, Foot & Ankle at Enovis, directs the strategic growth and product innovation for the specialized foot and ankle division. Overseeing the entire lifecycle of these medical solutions, the Global President and General Manager, Foot & Ankle ensures that the portfolio provides surgeons with the tools necessary for effective patient care. This leadership role involves expanding the market reach of foot and ankle technologies through targeted clinical education and strategic sales initiatives. By focusing on the specific requirements of podiatric and orthopedic specialists, Gary Justak directly impacts the quality of patient outcomes in this niche segment. Furthermore, the Global President and General Manager, Foot & Ankle collaborates with engineering teams to refine product designs and enhance the clinical value of the offerings. Through dedicated leadership, Justak drives the success of the division within the broader medical technology market.

Oliver Engert, the Chief Administrative Officer at Enovis, directs the internal infrastructure and operational support systems that enable global business functions. Overseeing corporate governance, human capital management, and organizational efficiency, the Chief Administrative Officer ensures that internal processes support the delivery of high-quality medical technology solutions. This leadership role involves streamlining cross-functional workflows to improve productivity and foster a culture of continuous improvement. By implementing robust administrative frameworks, Oliver Engert directly impacts the operational agility of the company. Furthermore, the Chief Administrative Officer collaborates with other executive leaders to align organizational structure with the strategic goals of the firm. Through the optimization of internal services and the management of corporate resources, Engert facilitates a seamless environment where clinicians and surgeons receive the necessary support to enhance patient outcomes across the global healthcare ecosystem.